Cargando…
Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide, and its incidence continues to increase. Despite improvements in both medical and surgical therapies, HCC remains associated with poor outcomes due to its high rates of recurrence and mortality. Approximate...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627435/ https://www.ncbi.nlm.nih.gov/pubmed/36340753 http://dx.doi.org/10.4254/wjh.v14.i10.1862 |